High-level expression, purification, crystallization and preliminary X-ray crystallographic studies of the receptor-binding domain of botulinum neurotoxin serotype D (original) (raw)

High‐resolution crystal structures of the botulinum neurotoxin binding domains from subtypes A5 and A6

Amy Britton

FEBS Open Bio, 2020

View PDFchevron_right

Structural analysis of the receptor binding domain of botulinum neurotoxin serotype D

Howard Robinson

Biochemical and Biophysical Research Communications, 2010

View PDFchevron_right

Crystal structure of the receptor binding domain of the botulinum C–D mosaic neurotoxin reveals potential roles of lysines 1118 and 1136 in membrane interactions

Howard Robinson

Biochemical and Biophysical Research Communications, 2011

View PDFchevron_right

Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co‐receptor ganglioside

Kyle Gregory

FEBS Open Bio, 2020

View PDFchevron_right

Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding

Robert Gustafsson

Toxins

View PDFchevron_right

Crystal Structure of Botulinum Neurotoxin Type A in Complex with the Cell Surface Co-Receptor GT1b—Insight into the Toxin–Neuron Interaction

Pål Stenmark

PLoS Pathogens, 2008

View PDFchevron_right

The C Terminus of the Catalytic Domain of Type A Botulinum Neurotoxin May Facilitate Product Release from the Active Site

Robert Webb

Journal of Biological Chemistry, 2013

View PDFchevron_right

Expression, purification and comparative characterisation of enzymatically deactivated recombinant botulinum neurotoxin type A

Thuan phan van

The Botulinum J., 2008

View PDFchevron_right

Crystal Structure of the Botulinum Neurotoxin Type G Binding Domain: Insight into Cell Surface Binding

Pål Stenmark

Journal of Molecular Biology, 2010

View PDFchevron_right

Crystal Structures of Botulinum Neurotoxin Subtypes A4 and A5 Cell Binding Domains in Complex with Receptor Ganglioside

Kyle Gregory

Toxins, 2022

View PDFchevron_right

Production and characterization of a recombinant chimeric antigen consisting botulinum neurotoxin serotypes A, B and E binding subdomains

Valiollah Babaeipour

The Journal of toxicological sciences, 2010

View PDFchevron_right

Cloning, Expression, and One-Step Purification of the Minimal Essential Domain of the Light Chain of Botulinum Neurotoxin Type A

Bernhard Rupp

Protein Expression and Purification, 2000

View PDFchevron_right

Exchange of the HCC domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin

Andreas Rummel

FEBS Journal, 2011

View PDFchevron_right

High Yield Preparation of Functionally Active Catalytic-Translocation Domain Module of Botulinum Neurotoxin Type A That Exhibits Uniquely Different Enzyme Kinetics

Bal R Singh

The protein journal, 2017

View PDFchevron_right

Epitope Characterization and Variable Region Sequence of F1-40, a High-Affinity Monoclonal Antibody to Botulinum Neurotoxin Type A (Hall Strain)

Larry Stanker

PLoS ONE, 2009

View PDFchevron_right

Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity

Andreas Rummel, Thomas Binz

Nature, 2006

View PDFchevron_right

Separation of the components of type A botulinum neurotoxin complex by electrophoresis

Muhammad Bal

Toxicon, 2003

View PDFchevron_right

Molecular assembly of botulinum neurotoxin progenitor complexes

Nancy Shine

Proceedings of the National Academy of Sciences, 2013

View PDFchevron_right

Conformational sampling of the botulinum neurotoxin serotype a light chain: implications for inhibitor binding

krishna panchal

Bioorganic & Medicinal Chemistry, 2005

View PDFchevron_right

Protein Domain Analysis of C. botulinum Type A Neurotoxin and Its Relationship with Other Botulinum Serotypes

Uma Basavanna

2010

View PDFchevron_right

A Comprehensive Structural Analysis of Clostridium botulinum Neurotoxin A Cell-Binding Domain from Different Subtypes

Kyle Gregory

Toxins

View PDFchevron_right

Botulinum neurotoxin: unique folding of enzyme domain of the most-poisonous poison

Valeri Barsegov

Journal of Biomolecular Structure and Dynamics, 2014

View PDFchevron_right

The Botulinum Neurotoxin Complex and the Role of Ancillary Proteins

Bal R Singh

Molecular Aspects of Botulinum Neurotoxin, 2014

View PDFchevron_right

Antibody mapping to domains of botulinum neurotoxin serotype A in the complexed and uncomplexed forms

Flora Chen

Infection and Immunity, 1997

View PDFchevron_right

Dichain Structure of Botulinum Neurotoxin: Identification of Cleavage Sites in Types C, D, and F Neurotoxin Molecules

Hirokazu Kouguchi

Journal of Protein Chemistry, 1999

View PDFchevron_right

Molecular topography and secondary structure comparisons of botulinum neurotoxin types A, B and E

Bal R Singh

Molecular and Cellular Biochemistry, 1989

View PDFchevron_right

Expression and purification of catalytic domain of botulinum neurotoxin serotype ‘F’: immunological characterization and its application in detection

Shiv Yadav

Food Biotechnology, 2020

View PDFchevron_right

A historical and proteomic analysis of botulinum neurotoxin type/G

Adrian Woolfitt

BMC Microbiology, 2011

View PDFchevron_right

A novel role of C-terminus in introducing a functionally flexible structure critical for the biological activity of botulinum neurotoxin

Bal R Singh

Scientific reports, 2018

View PDFchevron_right

Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept

Andreas Rummel, Thomas Binz

Proceedings of the National Academy of Sciences, 2007

View PDFchevron_right